Tetrahedron Letters
Reinvestigation of acetylation of 3,4-dihydroxybenzaldehyde
and reconciliation of previously reported analytical data
Carlos Berenguer Albiñana , John J. Hayward , Tomas Hudlicky , Ales Machara b,
a,b
a
a,
⇑
⇑
a
Department of Chemistry, Brock University, 500 Glenridge Ave., St Catharines, ON L2S 3A1, Canada
Department of Organic Chemistry, Faculty of Science, Charles University in Prague, Hlavova 2030/8, 128 43 Prague 2, Czech Republic
b
a r t i c l e i n f o
a b s t r a c t
Article history:
Acetylation of 3,4-dihydroxybenzaldehyde was reinvestigated. The results in the regiochemical outcome
were analyzed in detail by NMR methods and compared with previously published data.
Ó 2016 Elsevier Ltd. All rights reserved.
Received 14 December 2015
Revised 18 January 2016
Accepted 20 January 2016
Available online 21 January 2016
Keywords:
Acylation
Regioselectivity
Rearrangement
NMR spectroscopy
Methanolysis
In a recent chemoenzymatic synthesis of ent-hydromorphone1
reported by our group the conversion of 3,4-dihydroxybenzalde-
hyde (1) to its 4-methoxymethyl ether (3) was required, as shown
in Scheme 1. The selective acetylation of the 3-hydroxyl group in 1
spectra appeared to be mixtures of 3- and 4-acetyl isomers, with
the 3-acetyl isomer predominating (the data in Table 1, entries 1,
6, and 7 are listed for the major isomer). We also noticed that
the NMR spectra of a freshly crystallized product with a sharp
melting point showed varying ratios of the 3- and 4-acetyl isomers
depending on the length of time in solution. To clear up the confu-
sion we examined the acylation of 1 and the analysis of products in
greater detail in order to reconcile the widely differing data for
acetate 2. To this end we prepared the compound by the available
2
was performed by a procedure previously reported by Wandless
in his synthesis of ustilotoxin D and derived from the earlier work
3
of the Wightman group.
We have embarked on the second-generation synthesis of
hydromorphone where we wished to replace Pb(OAc)
4
in the
1
,2,6
oxidative dearomatization step with other reagents and possibly
also with electrochemical oxidation. To accomplish this task, large
amounts of the model compound 4 were prepared as shown in
Scheme 2. Repetition of our procedure1 for the synthesis of 2,
resulted in a material whose melting point value (115 °C) as well
literature methods
analyzing the progress of acylation (vide
NMR) and comparing the NMR spectra recorded in several different
deuterated solvents (see Supplementary material).
The discrepancy in the melting point values may be easily
6
explained by different polymorphs obtained on workup and crys-
1
as the H NMR data differed substantially from the data previously
tallization of the product. The variations in NMR data and/or
appearance of additional signals can be explained by the equilibra-
tion of acetyl isomers at 3- and 4-positions as it is well known that
acyl groups undergo 1,2- or 1,3-migrations to adjacent nucleophilic
1
reported by us (mp = 88–91 °C). Examination of older published
data revealed inconsistencies in melting point values as well as
in NMR data, as summarized in Table 1.
The discrepancy in melting point values initially led us to sus-
pect that we may have obtained the regioisomer acylated at the
7
groups. The observed ratios of the 3- and 4-acetyl isomers are
dependent on the solvent and the time the product remains in
solution prior to the NMR experiment (see Supporting information
for the results of monitoring).
4
-position. The melting point of 115 °C we obtained agreed with
4
5
the value reported by Hänsel and Pascu but not with that previ-
ously reported by us and by Wightman.3 In addition, the NMR
1
NMR analysis of 2 in CDCl
- and 4-acetyl isomers that equilibrates to about 80:20 after about
0 min. To investigate the isomerism of 2 in CDCl , spectra were
3
shows an initial 96:4 ratio of the
3
3
3
⇑
obtained every 5 min over the course of an hour. Exchange Spec-
troscopy (EXSY) spectra show a small positive enhancement of
(
A. Machara).
040-4039/Ó 2016 Elsevier Ltd. All rights reserved.
0